Ayurveda

Global Ayurveda Market to Reach US$74.3 Billion by 2030

The global market for Ayurveda estimated at US$17.8 Billion in the year 2024, is expected to reach US$74.3 Billion by 2030, growing at a CAGR of 26.9% over the analysis period 2024-2030. Herbal Form, one of the segments analyzed in the report, is expected to record a 29.6% CAGR and reach US$47.5 Billion by the end of the analysis period. Growth in the Mineral Form segment is estimated at 23.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.8 Billion While China is Forecast to Grow at 35.8% CAGR

The Ayurveda market in the U.S. is estimated at US$4.8 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$18.7 Billion by the year 2030 trailing a CAGR of 35.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 21.4% and 24.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 22.8% CAGR.

Global Ayurveda Market – Key Trends & Drivers Summarized

Why Is Ayurveda Experiencing a Resurgence?
The Ayurveda market is growing due to increasing consumer preference for natural and holistic healthcare solutions. The rising awareness of traditional medicine and wellness therapies has led to higher demand for Ayurvedic formulations. Government support for Ayurveda research and global regulatory approvals for herbal medicines have further propelled market growth. Additionally, the expansion of Ayurvedic skincare, nutraceuticals, and personalized wellness programs has diversified industry offerings. The incorporation of Ayurveda into mainstream healthcare and its integration with modern medical practices have also contributed to the industry’s rapid expansion. Increasing healthcare costs and concerns over the side effects of synthetic drugs have driven many consumers toward natural and preventive healthcare approaches, boosting Ayurveda’s adoption worldwide.

How Are Technological Advancements Shaping the Ayurveda Market?
The Ayurveda industry is undergoing significant transformation due to advancements in biotechnology, extraction techniques, and formulation sciences. Modern research methodologies have enabled the standardization and quality control of Ayurvedic medicines, ensuring their efficacy and safety. AI and big data analytics are being employed to create personalized Ayurvedic treatment plans based on genetic predisposition and lifestyle factors. Additionally, nano-formulations and encapsulation technologies have improved the bioavailability of Ayurvedic herbs, enhancing their therapeutic potential. Digital health platforms and telemedicine are further expanding Ayurveda’s reach, allowing consumers to access expert consultations and personalized herbal remedies online.

Why Are Global Players and Investors Increasingly Entering the Ayurveda Market?
The Ayurveda market is attracting substantial investments from global healthcare companies, startups, and venture capital firms. Leading pharmaceutical and cosmetic companies are launching Ayurvedic product lines to cater to the rising demand for natural wellness solutions. Cross-industry collaborations are fostering innovation in Ayurvedic formulations, skincare, and dietary supplements. The increasing acceptance of Ayurveda in Western markets has led to the expansion of Ayurvedic brands into international territories, with growing consumer interest in herbal remedies. Furthermore, government initiatives promoting Ayurveda through research funding, export incentives, and regulatory frameworks have bolstered industry confidence, encouraging new entrants and business expansion.

What Are the Key Growth Drivers of the Ayurveda Market?
The growth of the Ayurveda market is driven by several factors, including the rising popularity of natural and holistic healthcare, increasing research into Ayurvedic formulations, and the integration of Ayurveda with modern medical practices. Consumer preference for chemical-free beauty and personal care products has further expanded the demand for Ayurvedic skincare and cosmetics. The rising trend of preventive healthcare and self-care, especially post-pandemic, has accelerated the adoption of Ayurvedic immunity-boosting and wellness products. Additionally, government initiatives supporting traditional medicine, along with the expansion of e-commerce platforms, have made Ayurvedic products more accessible to a global audience. The increasing presence of Ayurvedic hospitals, wellness retreats, and alternative therapy centers is further driving consumer trust and industry growth, positioning Ayurveda as a mainstream wellness solution worldwide.

SCOPE OF STUDY:

The report analyzes the Ayurveda market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Form (Herbal Form, Mineral Form, Herbomineral Form); Indication (Skin/Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication, Cardiovascular Systems Indication, Other Indications); Distribution Channel (Direct Sales Distribution Channels, Distance Correspondence Distribution Channels, E-Sales Distribution Channels); Application (Personal Application, Medical/Therapy Application); End-Use (Clinics End-Use, Hospitals End-Use, Academia and Research End-Use)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -
  • Amrutanjan Health Care Ltd.
  • Bioveda Action Research Company
  • Charak Pharma Pvt. Ltd.
  • Cancer Research UK
  • Dabur India Ltd
  • Forest Essentials
  • Hamdard Laboratories
  • Himalaya Wellness Company
  • Kerala Ayurveda Ltd.
  • Patanjali Ayurved Limited
  • Shree Baidyanath Ayurved Bhawan Pvt. Ltd.
  • The Arya Vaidya Pharmacy (Coimbatore) Ltd.
  • Vicco Laboratories

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Ayurveda – Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Global Shift Toward Holistic Wellness and Preventive Healthcare Throws the Spotlight on Ayurveda as a Mainstream Alternative
Rising Consumer Demand for Natural and Plant-Based Products Propels Growth of Ayurvedic Personal Care and Nutrition
Increased Focus on Immunity, Stress Relief, and Lifestyle Management Accelerates Adoption of Ayurveda Post-Pandemic
Expansion of Ayurvedic Offerings in E-Commerce and DTC Channels Strengthens Market Reach and Consumer Accessibility
Integration of Ayurveda with Modern Diagnostics and Wellness Platforms Expands the Addressable Market in Functional Health
Innovation in Ayurvedic Formulations and Standardized Extracts Spurs Growth in Nutraceutical and Cosmeceutical Segments
Digitization of Ayurvedic Consultations and Personalized Wellness Apps Reinforces Ayurveda`s Position in Tech-Enabled Healthcare
Rising Demand for Clean Label and Chemical-Free Alternatives Sustains Long-Term Interest in Ayurvedic Skincare and Haircare
Urbanization and Lifestyle Disorders Create Opportunities for Ayurvedic Solutions in Stress, Sleep, and Metabolic Health
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Ayurveda Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Ayurveda by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Ayurveda by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Ayurveda by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Herbal Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Herbal Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for Herbal Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Mineral Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Mineral Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Mineral Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Herbomineral Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Herbomineral Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Herbomineral Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Skin / Hair Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Skin / Hair Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Skin / Hair Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for GI Tract Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for GI Tract Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 22: World 15-Year Perspective for GI Tract Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Infectious Diseases Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 24: World Historic Review for Infectious Diseases Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 25: World 15-Year Perspective for Infectious Diseases Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Respiratory Systems Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 27: World Historic Review for Respiratory Systems Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 28: World 15-Year Perspective for Respiratory Systems Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Nervous Systems Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 30: World Historic Review for Nervous Systems Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 31: World 15-Year Perspective for Nervous Systems Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Cardiovascular Systems Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 33: World Historic Review for Cardiovascular Systems Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 34: World 15-Year Perspective for Cardiovascular Systems Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for Direct Sales Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 36: World Historic Review for Direct Sales Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 37: World 15-Year Perspective for Direct Sales Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 38: World Recent Past, Current & Future Analysis for Distance Correspondence Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 39: World Historic Review for Distance Correspondence Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 40: World 15-Year Perspective for Distance Correspondence Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 41: World Recent Past, Current & Future Analysis for E-Sales Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 42: World Historic Review for E-Sales Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 43: World 15-Year Perspective for E-Sales Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 44: World Recent Past, Current & Future Analysis for Personal Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 45: World Historic Review for Personal Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 46: World 15-Year Perspective for Personal Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 47: World Recent Past, Current & Future Analysis for Medical / Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 48: World Historic Review for Medical / Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 49: World 15-Year Perspective for Medical / Therapy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 50: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 51: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 52: World 15-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 53: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 54: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 55: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 56: World Recent Past, Current & Future Analysis for Academia & Research End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 57: World Historic Review for Academia & Research End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 58: World 15-Year Perspective for Academia & Research End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 59: USA Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 60: USA Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 61: USA 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 62: USA Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: USA Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 64: USA 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 65: USA Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 66: USA Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 67: USA 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 68: USA Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: USA Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 70: USA 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 71: USA Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 72: USA Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 73: USA 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
CANADA
TABLE 74: Canada Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: Canada Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 76: Canada 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 77: Canada Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 78: Canada Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 79: Canada 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 80: Canada Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: Canada Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 82: Canada 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 83: Canada Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 84: Canada Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 85: Canada 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 86: Canada Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: Canada Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 88: Canada 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
JAPAN
Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 89: Japan Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 90: Japan Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 91: Japan 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 92: Japan Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: Japan Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 94: Japan 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 95: Japan Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 96: Japan Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 97: Japan 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 98: Japan Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: Japan Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 100: Japan 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 101: Japan Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 102: Japan Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 103: Japan 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
CHINA
Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 104: China Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: China Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 106: China 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 107: China Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 108: China Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 109: China 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 110: China Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 111: China Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 112: China 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 113: China Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 114: China Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 115: China 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 116: China Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 117: China Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 118: China 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
EUROPE
Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 119: Europe Recent Past, Current & Future Analysis for Ayurveda by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 120: Europe Historic Review for Ayurveda by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 121: Europe 15-Year Perspective for Ayurveda by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 122: Europe Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 123: Europe Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 124: Europe 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 125: Europe Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 126: Europe Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 127: Europe 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 128: Europe Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 129: Europe Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 130: Europe 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 131: Europe Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 132: Europe Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 133: Europe 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 134: Europe Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 135: Europe Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 136: Europe 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
FRANCE
Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 137: France Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 138: France Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 139: France 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 140: France Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 141: France Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 142: France 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 143: France Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 144: France Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 145: France 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 146: France Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 147: France Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 148: France 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 149: France Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 150: France Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 151: France 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
GERMANY
Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 152: Germany Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 153: Germany Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 154: Germany 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 155: Germany Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 156: Germany Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 157: Germany 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 158: Germany Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 159: Germany Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 160: Germany 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 161: Germany Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 162: Germany Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 163: Germany 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 164: Germany Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 165: Germany Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 166: Germany 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
ITALY
TABLE 167: Italy Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 168: Italy Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 169: Italy 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 170: Italy Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 171: Italy Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 172: Italy 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 173: Italy Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 174: Italy Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 175: Italy 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 176: Italy Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 177: Italy Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 178: Italy 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 179: Italy Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 180: Italy Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 181: Italy 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
UNITED KINGDOM
Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 182: UK Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 183: UK Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 184: UK 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 185: UK Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 186: UK Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 187: UK 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 188: UK Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 189: UK Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 190: UK 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 191: UK Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 192: UK Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 193: UK 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 194: UK Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 195: UK Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 196: UK 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
SPAIN
TABLE 197: Spain Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 198: Spain Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 199: Spain 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 200: Spain Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 201: Spain Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 202: Spain 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 203: Spain Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 204: Spain Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 205: Spain 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 206: Spain Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 207: Spain Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 208: Spain 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 209: Spain Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 210: Spain Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 211: Spain 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
RUSSIA
TABLE 212: Russia Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 213: Russia Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 214: Russia 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 215: Russia Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 216: Russia Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 217: Russia 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 218: Russia Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 219: Russia Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 220: Russia 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 221: Russia Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 222: Russia Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 223: Russia 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 224: Russia Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 225: Russia Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 226: Russia 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 227: Rest of Europe Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 228: Rest of Europe Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 229: Rest of Europe 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 230: Rest of Europe Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 231: Rest of Europe Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 232: Rest of Europe 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 233: Rest of Europe Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 234: Rest of Europe Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 235: Rest of Europe 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 236: Rest of Europe Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 237: Rest of Europe Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 238: Rest of Europe 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 239: Rest of Europe Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 240: Rest of Europe Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 241: Rest of Europe 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 242: Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 243: Asia-Pacific Historic Review for Ayurveda by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 244: Asia-Pacific 15-Year Perspective for Ayurveda by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
TABLE 245: Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 246: Asia-Pacific Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 247: Asia-Pacific 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 248: Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 249: Asia-Pacific Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 250: Asia-Pacific 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 251: Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 252: Asia-Pacific Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 253: Asia-Pacific 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 254: Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 255: Asia-Pacific Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 256: Asia-Pacific 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 257: Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 258: Asia-Pacific Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 259: Asia-Pacific 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
AUSTRALIA
Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 260: Australia Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 261: Australia Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 262: Australia 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 263: Australia Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 264: Australia Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 265: Australia 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 266: Australia Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 267: Australia Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 268: Australia 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 269: Australia Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 270: Australia Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 271: Australia 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 272: Australia Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 273: Australia Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 274: Australia 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
INDIA
Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 275: India Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 276: India Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 277: India 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 278: India Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 279: India Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 280: India 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 281: India Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 282: India Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 283: India 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 284: India Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 285: India Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 286: India 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 287: India Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 288: India Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 289: India 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
SOUTH KOREA
TABLE 290: South Korea Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 291: South Korea Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 292: South Korea 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 293: South Korea Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 294: South Korea Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 295: South Korea 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 296: South Korea Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 297: South Korea Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 298: South Korea 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 299: South Korea Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 300: South Korea Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 301: South Korea 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 302: South Korea Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 303: South Korea Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 304: South Korea 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 305: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 306: Rest of Asia-Pacific Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 307: Rest of Asia-Pacific 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 308: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 309: Rest of Asia-Pacific Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 310: Rest of Asia-Pacific 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 311: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 312: Rest of Asia-Pacific Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 313: Rest of Asia-Pacific 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 314: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 315: Rest of Asia-Pacific Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 316: Rest of Asia-Pacific 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 317: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 318: Rest of Asia-Pacific Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 319: Rest of Asia-Pacific 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
LATIN AMERICA
Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 320: Latin America Recent Past, Current & Future Analysis for Ayurveda by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 321: Latin America Historic Review for Ayurveda by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 322: Latin America 15-Year Perspective for Ayurveda by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
TABLE 323: Latin America Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 324: Latin America Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 325: Latin America 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 326: Latin America Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 327: Latin America Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 328: Latin America 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 329: Latin America Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 330: Latin America Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 331: Latin America 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 332: Latin America Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 333: Latin America Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 334: Latin America 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 335: Latin America Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 336: Latin America Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 337: Latin America 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
ARGENTINA
TABLE 338: Argentina Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 339: Argentina Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 340: Argentina 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 341: Argentina Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 342: Argentina Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 343: Argentina 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 344: Argentina Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 345: Argentina Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 346: Argentina 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 347: Argentina Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 348: Argentina Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 349: Argentina 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 350: Argentina Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 351: Argentina Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 352: Argentina 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
BRAZIL
TABLE 353: Brazil Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 354: Brazil Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 355: Brazil 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 356: Brazil Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 357: Brazil Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 358: Brazil 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 359: Brazil Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 360: Brazil Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 361: Brazil 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 362: Brazil Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 363: Brazil Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 364: Brazil 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 365: Brazil Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 366: Brazil Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 367: Brazil 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
MEXICO
TABLE 368: Mexico Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 369: Mexico Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 370: Mexico 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 371: Mexico Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 372: Mexico Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 373: Mexico 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 374: Mexico Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 375: Mexico Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 376: Mexico 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 377: Mexico Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 378: Mexico Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 379: Mexico 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 380: Mexico Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 381: Mexico Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 382: Mexico 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
TABLE 383: Rest of Latin America Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 384: Rest of Latin America Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 385: Rest of Latin America 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 386: Rest of Latin America Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 387: Rest of Latin America Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 388: Rest of Latin America 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 389: Rest of Latin America Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 390: Rest of Latin America Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 391: Rest of Latin America 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 392: Rest of Latin America Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 393: Rest of Latin America Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 394: Rest of Latin America 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 395: Rest of Latin America Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 396: Rest of Latin America Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 397: Rest of Latin America 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
MIDDLE EAST
Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 398: Middle East Recent Past, Current & Future Analysis for Ayurveda by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 399: Middle East Historic Review for Ayurveda by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 400: Middle East 15-Year Perspective for Ayurveda by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
TABLE 401: Middle East Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 402: Middle East Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 403: Middle East 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 404: Middle East Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 405: Middle East Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 406: Middle East 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 407: Middle East Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 408: Middle East Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 409: Middle East 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 410: Middle East Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 411: Middle East Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 412: Middle East 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 413: Middle East Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 414: Middle East Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 415: Middle East 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
IRAN
TABLE 416: Iran Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 417: Iran Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 418: Iran 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 419: Iran Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 420: Iran Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 421: Iran 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 422: Iran Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 423: Iran Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 424: Iran 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 425: Iran Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 426: Iran Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 427: Iran 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 428: Iran Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 429: Iran Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 430: Iran 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
ISRAEL
TABLE 431: Israel Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 432: Israel Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 433: Israel 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 434: Israel Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 435: Israel Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 436: Israel 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 437: Israel Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 438: Israel Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 439: Israel 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 440: Israel Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 441: Israel Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 442: Israel 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 443: Israel Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 444: Israel Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 445: Israel 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
SAUDI ARABIA
TABLE 446: Saudi Arabia Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 447: Saudi Arabia Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 448: Saudi Arabia 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 449: Saudi Arabia Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 450: Saudi Arabia Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 451: Saudi Arabia 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 452: Saudi Arabia Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 453: Saudi Arabia Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 454: Saudi Arabia 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 455: Saudi Arabia Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 456: Saudi Arabia Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 457: Saudi Arabia 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 458: Saudi Arabia Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 459: Saudi Arabia Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 460: Saudi Arabia 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 461: UAE Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 462: UAE Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 463: UAE 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 464: UAE Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 465: UAE Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 466: UAE 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 467: UAE Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 468: UAE Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 469: UAE 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 470: UAE Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 471: UAE Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 472: UAE 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 473: UAE Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 474: UAE Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 475: UAE 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
TABLE 476: Rest of Middle East Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 477: Rest of Middle East Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 478: Rest of Middle East 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 479: Rest of Middle East Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 480: Rest of Middle East Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 481: Rest of Middle East 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 482: Rest of Middle East Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 483: Rest of Middle East Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 484: Rest of Middle East 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 485: Rest of Middle East Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 486: Rest of Middle East Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 487: Rest of Middle East 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 488: Rest of Middle East Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 489: Rest of Middle East Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 490: Rest of Middle East 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
AFRICA
Ayurveda Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 491: Africa Recent Past, Current & Future Analysis for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 492: Africa Historic Review for Ayurveda by Form - Herbal Form, Mineral Form and Herbomineral Form Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 493: Africa 15-Year Perspective for Ayurveda by Form - Percentage Breakdown of Value Sales for Herbal Form, Mineral Form and Herbomineral Form for the Years 2015, 2025 & 2030
TABLE 494: Africa Recent Past, Current & Future Analysis for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 495: Africa Historic Review for Ayurveda by Indication - Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 496: Africa 15-Year Perspective for Ayurveda by Indication - Percentage Breakdown of Value Sales for Other Indications, Skin / Hair Indication, GI Tract Indication, Infectious Diseases Indication, Respiratory Systems Indication, Nervous Systems Indication and Cardiovascular Systems Indication for the Years 2015, 2025 & 2030
TABLE 497: Africa Recent Past, Current & Future Analysis for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 498: Africa Historic Review for Ayurveda by Distribution Channel - Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 499: Africa 15-Year Perspective for Ayurveda by Distribution Channel - Percentage Breakdown of Value Sales for Direct Sales Distribution Channels, Distance Correspondence Distribution Channels and E-Sales Distribution Channels for the Years 2015, 2025 & 2030
TABLE 500: Africa Recent Past, Current & Future Analysis for Ayurveda by Application - Personal Application and Medical / Therapy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 501: Africa Historic Review for Ayurveda by Application - Personal Application and Medical / Therapy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 502: Africa 15-Year Perspective for Ayurveda by Application - Percentage Breakdown of Value Sales for Personal Application and Medical / Therapy Application for the Years 2015, 2025 & 2030
TABLE 503: Africa Recent Past, Current & Future Analysis for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 504: Africa Historic Review for Ayurveda by End-Use - Clinics End-Use, Hospitals End-Use and Academia & Research End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 505: Africa 15-Year Perspective for Ayurveda by End-Use - Percentage Breakdown of Value Sales for Clinics End-Use, Hospitals End-Use and Academia & Research End-Use for the Years 2015, 2025 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings